Optimierte Detektion und Charakterisierung von Lebermetastasen: Leistungsvermögen aktueller MRT‑Kontrastmittel
Standard
Optimierte Detektion und Charakterisierung von Lebermetastasen: Leistungsvermögen aktueller MRT‑Kontrastmittel. / Weinrich, J M; Well, L; Bannas, P.
in: RADIOLOGE, Jahrgang 57, Nr. 5, 05.2017, S. 373-381.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Optimierte Detektion und Charakterisierung von Lebermetastasen: Leistungsvermögen aktueller MRT‑Kontrastmittel
AU - Weinrich, J M
AU - Well, L
AU - Bannas, P
PY - 2017/5
Y1 - 2017/5
N2 - Metastases are the most common malignant lesions of the liver. The presence of liver metastases is an important prognostic factor and is decisive for the further management, especially in patients with colorectal cancer. Detection and characterization of liver metastases as well as differentiation from benign lesions are of high importance and a daily challenge in clinical radiology. Contrast-enhanced magnetic resonance imaging (MRI) has the highest sensitivity in detecting liver metastases. The sensitivity of MRI has been further increased due to the development of liver-specific contrast agents. This article describes the role of extracellular and hepatobiliary contrast agents for the detection and characterization of liver metastases. Moreover, the current knowledge on safety, sequence optimization, transient severe dyspnea and the combination of hepatobiliary with intravascular contrast agents for liver imaging is discussed.
AB - Metastases are the most common malignant lesions of the liver. The presence of liver metastases is an important prognostic factor and is decisive for the further management, especially in patients with colorectal cancer. Detection and characterization of liver metastases as well as differentiation from benign lesions are of high importance and a daily challenge in clinical radiology. Contrast-enhanced magnetic resonance imaging (MRI) has the highest sensitivity in detecting liver metastases. The sensitivity of MRI has been further increased due to the development of liver-specific contrast agents. This article describes the role of extracellular and hepatobiliary contrast agents for the detection and characterization of liver metastases. Moreover, the current knowledge on safety, sequence optimization, transient severe dyspnea and the combination of hepatobiliary with intravascular contrast agents for liver imaging is discussed.
KW - English Abstract
KW - Journal Article
U2 - 10.1007/s00117-017-0214-2
DO - 10.1007/s00117-017-0214-2
M3 - SCORING: Zeitschriftenaufsatz
C2 - 28204853
VL - 57
SP - 373
EP - 381
JO - RADIOLOGE
JF - RADIOLOGE
SN - 0033-832X
IS - 5
ER -
